Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe

Journals Blog

  • Visit AAP News on Facebook
  • Follow AAP News on Twitter

The Ethics of COVID-19 Research in Children

Suzanne B. Haney, MD, MS, FAAP, Editorial Board Member, Pediatrics
October 07, 2020

As we rush to develop better and more effective treatments and vaccines to combat the COVID-19 pandemic, we cannot forget about the concerns and risks in conducting research, especially in vulnerable populations like children. This month’s Ethics Rounds in Pediatrics (2020-010728) reviews the ethics behind testing a COVID-19 treatment on a particularly vulnerable child who has no parents to consent for care or research.

As with any clinical trial, researchers need to weigh the risks and possible benefits for each patient. However, clinical trials should be conducted from a starting point of equipoise: where both arms of the trial are designed to have potentially the same outcome and thus offer the same risk/benefit ratio to any study subject. Thus the real question is whether or not to participate in the study at all.

Therefore, it is easy to argue that vulnerable patients should not participate in research. To that point, in Nebraska, there is a state policy which prevents any state ward from participating in research. This policy was put into place to protect state wards from the risk of research. However, it is also true that by preventing a population from participating in research, they may be excluded from the benefits of research. For example, we know that children in foster care are at higher risk for post-traumatic stress disorder (PTSD) as a result of adverse childhood experiences. If we were studying a drug which mitigated the effects of PTSD, but excluded those children in foster care, we may find an overall effect that is smaller or may even miss an adverse event that occurs because of the high burden of trauma in this population.

It is true that there are vulnerable populations which are identified at high risk during clinical research trials. Rather than completely excluding these vulnerable populations from clinical trials, there needs to be an ethical discussion weighing the risks and benefits of participation for each study and possibly (as in this case) for each patient.

  • A Call for Pediatric COVID-19 Clinical Trials
  • Applying Evidence From Clinical Trials: Need for Pediatric Learning Health System Research
  • Pediatric Critical Care and COVID-19
  • Facebook
  • Instagram
Copyright © 2020 American Academy of Pediatrics

Advertising Disclaimer »

Download PDF
Share
The Ethics of COVID-19 Research in Children
Suzanne B. Haney, MD, MS, FAAP
October 07, 2020
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Email Blog Post

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Ethics of COVID-19 Research in Children
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Digital Edition Current Issue
  • Latest Daily News
  • Archives
  • Collections
  • Columns
  • Advertising
  • Subscribe to AAP News Magazine
  • Terms of Use
  • Privacy Statement
  • FAQ
  • Contact Us
  • 2021 AAP Journals Catalog
  • Pediatrics
  • Pediatrics in Review
  • Hospital Pediatrics
  • NeoReviews
  • AAP Grand Rounds
  • AAP Career Center
  • shopAAP
  • AAP.org
  • AAP News
  • Visit AAP News on Facebook
  • Follow AAP News on Twitter
American Academy of Pediatrics

© 2021 American Academy of Pediatrics